The effects of rifaximin and lactulose on the gut-liver-brain axis in rats with minimal hepatic encephalopathy.
<h4>Background</h4>The principal therapeutic agents for minimal hepatic encephalopathy (MHE), which focus on the modulation of the gut microbiota, include lactulose and rifaximin; however, the precise mechanisms through which they operate remain unclear.<h4>Aim</h4>This study...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0325988 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|